These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4733330)

  • 1. Oral antigastric acid secretory activity of synthetic prostaglandin analogues (9-oxoprostanoic acids).
    Lippmann W
    Experientia; 1973 Aug; 29(8):990-1. PubMed ID: 4733330
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of gastric acid secretion in the rat by orally-administered synthetic prostaglandin analogues: enantiomorphs of 15-hydroxy-15-methyl-9-oxoprostanoic acid.
    Lippmann W
    J Pharm Pharmacol; 1974 Oct; 26(10):831-3. PubMed ID: 4156547
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):223-9. PubMed ID: 4414938
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):231-46. PubMed ID: 4413891
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of gastric acid secretion in the rat by synthetic prostaglandin analogues.
    Lippmann W
    Ann N Y Acad Sci; 1971 Apr; 180():332-5. PubMed ID: 5286101
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.
    Karim SM; Carter DC; Bhana D; Ganesan PA
    Br Med J; 1973 Jan; 1(5846):143-6. PubMed ID: 4706806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins and congeners. Synthesis of simplified prostaglandins. Inhibition of gastric acid secretion by 2-(omega-carboxyalkyl)-3-alkylcycloalkanones.
    Poletto JF; Bernady KF; Kupfer D; Partridge R; Weiss MJ
    J Med Chem; 1975 Apr; 18(4):359-62. PubMed ID: 1121001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins.
    Whittle BJ
    Eur J Pharmacol; 1976 Dec; 40(2):233-9. PubMed ID: 11107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gastric acid secretion in vitro by prostaglandin E1.
    Way L; Durbin RP
    Nature; 1969 Mar; 221(5183):874-5. PubMed ID: 4303810
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of human gastric secretion by prostaglandin.
    Carter DC; Karim SM; Bhana D; Ganesan PA
    Br J Surg; 1973 Oct; 60(10):828-31. PubMed ID: 4748390
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anti-ulcer activity of a synthetic prostaglandin analogue (9-oxoprostanoic acid: AY-22,469).
    Lippmann W; Seethaler K
    Experientia; 1973 Aug; 29(8):993-5. PubMed ID: 4733332
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of prostaglandins on the stomach and the intestine.
    Robert A
    Prostaglandins; 1974 Jun; 6(6):523-32. PubMed ID: 4366018
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of gastric acid secretion by a potent synthetic prostaglandin.
    Lippmann W
    J Pharm Pharmacol; 1970 Jan; 22(1):65-7. PubMed ID: 4391752
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat.
    Main IH; Whittle BJ
    Br J Pharmacol; 1973 Nov; 49(3):428-36. PubMed ID: 4149696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of prostaglandins on stomach's secretory activity].
    Swiderska-Kulikowa B
    Pol Arch Med Wewn; 1974 Sep; 52(3):299-303. PubMed ID: 4607910
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostaglandin inhibition of gastric secretion.
    Ramwell PW; Shaw JE
    J Physiol; 1968 Mar; 195(2):34P-36P. PubMed ID: 5647329
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of SC-19220 to affect prostaglandin E1 (PGR1) gastric antisecretory actions.
    Engel JJ; Scruggs W; Wilson DE
    Prostaglandins; 1973 Jul; 4(1):65-70. PubMed ID: 4199539
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of indomethacin-induced gastric ulceration in the rat by perorally-administered synthetic and natural prostaglandin analogues.
    Lippmann W
    Prostaglandins; 1974 Jul; 7(1):1-10. PubMed ID: 4852476
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat.
    Robert A; Nezamis JE; Phillips JP
    Gastroenterology; 1968 Oct; 55(4):481-7. PubMed ID: 5698627
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of prostaglandin E 1 on the basal gastric secretion in man].
    Classen M; Koch H; Deyhle P; Weidenhiller S; Demling L
    Klin Wochenschr; 1970 Jul; 48(14):876-8. PubMed ID: 5522177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.